Laura González-Lafuente Selected Research

ethyl 5- amino- 2- methyl- 6,7,8,9- tetrahydrobenzo(b)(1,8)naphthyridine- 3- carboxylate

9/2013

PP2A ligand ITH12246 protects against memory impairment and focal cerebral ischemia in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Laura González-Lafuente Research Topics

Disease

3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2016 - 09/2013
3	Brain Ischemia (Cerebral Ischemia) 12/2015 - 01/2011
3	Neuroblastoma 01/2011 - 08/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2022
2	Cardiomegaly (Heart Hypertrophy) 01/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 01/2016 - 09/2013
2	Infarction (Infarctions) 12/2015 - 09/2013
2	Vascular Diseases (Vascular Disease) 01/2011 - 08/2010
1	Reperfusion Injury 02/2022
1	Uremia 01/2022
1	Acute Kidney Injury (Acute Renal Failure) 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Long QT Syndrome 01/2022
1	Fibrosis (Cirrhosis) 01/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 12/2020
1	Stroke (Strokes) 12/2015
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2015
1	Neuroinflammatory Diseases 01/2015
1	Memory Disorders (Memory Loss) 09/2013
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2011

Drug/Important Bio-Agent (IBA)

3	AntioxidantsIBA 12/2015 - 01/2011
3	Neuroprotective AgentsIBA 12/2015 - 01/2011
3	MelatoninIBA 12/2015 - 09/2013
3	RotenoneIBA 01/2011 - 08/2010
3	oligomycin AIBA 01/2011 - 08/2010
2	CalciumIBA 02/2022 - 01/2022
2	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 01/2022 - 01/2022
2	MineralsIBA 01/2022 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2016 - 01/2015
2	Cholinergic Agents (Cholinergics)IBA 01/2011 - 08/2010
1	Troponin T (Troponin T1)IBA 01/2022
1	Fibroblast Growth Factor-23IBA 01/2022
1	Calmodulin (Calcium-Dependent Activator Protein)IBA 01/2022
1	Ryanodine Receptor Calcium Release Channel (Ryanodine Receptor)IBA 01/2022
1	phospholambanIBA 01/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	Phosphorus (Red Phosphorus)IBA 01/2022
1	Phosphotransferases (Kinase)IBA 01/2022
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 01/2022
1	Spironolactone (Aldactone)FDA LinkGeneric 01/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2021
1	pro-brain natriuretic peptide (1-76)IBA 12/2020
1	oxidized low density lipoproteinIBA 12/2020
1	Brain Natriuretic Peptide (Natrecor)FDA Link 12/2020
1	gramineIBA 01/2016
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2016
1	Glutamic Acid (Glutamate)FDA Link 12/2015
1	MT2 Melatonin ReceptorIBA 12/2015
1	Oxygen (Dioxygen)IBA 12/2015
1	Melatonin Receptors (Melatonin Receptor)IBA 12/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2015
1	Glucose (Dextrose)FDA LinkGeneric 12/2015
1	N- (2- (5- methoxy- indol- 3- yl)- ethyl)- 4- oxo- 4H- pyran- 2- carboxamideIBA 12/2015
1	CinnamatesIBA 01/2015
1	LigandsIBA 09/2013
1	Pharmaceutical PreparationsIBA 09/2013
1	Galantamine (Galanthamine)FDA LinkGeneric 09/2013
1	ethyl 5- amino- 2- methyl- 6,7,8,9- tetrahydrobenzo(b)(1,8)naphthyridine- 3- carboxylateIBA 09/2013
1	Scopolamine (Hyoscine)FDA Link 09/2013
1	Muscarinic AntagonistsIBA 09/2013
1	nitronesIBA 01/2011
1	Tacrine (Cognex)FDA Link 01/2011
1	compound 17IBA 08/2010